Hereditary eye diseases are characterised by strong genetic heterogeneity and overlapping clinical presentations. Molecular genetic testing often helps establish a specific diagnosis and, in the context of clinical assessment, predict the expected progression of the disorder and initiate targeted treatment.
A | Achromatopsia |
C | Cone-rod dystrophy |
F | Flecked retina syndrome |
L | Leber congenital amaurosis (LCA) |
Leber hereditary optic neuropathy (LHON) | |
N | Night blindness, congenital stationary X-linked |
Nystagmus | |
O | Optic atrophy |
P | Peroxisome biogenesis disorder |
R | Retinitis pigmentosa |
Retinoblastoma | |
S | Stargardt disease |
U | Usher syndrome type 1 |
Usher syndrome type 2 |
A | Albinism |
Anterior segment dysgenesis (ASD) disorders | |
C | Cataract |
Chediak-Higashi syndrome | |
Congenital fibrosis of the external eye muscles (CFEOM) | |
Corneal dystrophy | |
F | Familial exudative vitreoretinopathy |
G | Glaucoma |
Griscelli syndrome | |
H | Hermansky-Pudlak syndrome |
M | Microphthalmia |
R | Retinal detachment |
W | WAGR syndrome (Wilms tumor aniridia syndrome) |
A | Alagille syndrome |
Alport syndrome | |
B | Bardet-Biedl syndrome |
C | CHARGE syndrome |
H | Hyperoxaluria |
J | Joubert syndrome |
M | Mainzer-Saldino syndrome |
N | Norrie syndrome |
R | Refsum disease |
S | Senior-Loken syndrome |
Stickler syndrome | |
T | Tuberous Sclerosis Complex |
W | Waardenburg syndrome |